With conventional chemotherapy regimens, cytotoxicity-associated ovarian insufficiency involves PF pool depletion by apoptosis or hyperactivation mechanisms, notably mediated by the ABL/TAp63 and PI3K/Akt/mTOR pathways (Figure 5). This evidence concerns the gene MTOR and ovarian dysfunction.